Boston Scientific Corporation Welcomes FDA Statement On Drug-Eluting Stents

September 15, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NATICK, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX - News) today issued the following comment on the statement of the U.S. Food and Drug Administration on drug-eluting stents:

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)